(Q35119292)

English

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

multicenter clinical trial

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

2

object named as

Alan W Partin

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

6

object named as

Chris H Bangma

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

William J Catalona

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Martin G Sanda

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

John T Wei

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

George G Klee

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Kevin M Slawin

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Leonard S Marks

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Stacy Loeb

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Dennis L Broyles

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sanghyuk S Shin

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Amabelle B Cruz

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Daniel W Chan

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Lori J Sokoll

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

William L Roberts

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ron H N van Schaik

16

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Isaac A Mizrahi

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

17 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

185

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1650-1655

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

9 July 2018

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

27 September 2018

Prostate specific antigen assay standardization bias could affect clinical decision making.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

27 September 2018

New confidence intervals for the difference between two sensitivities at a fixed level of specificity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

27 September 2018

Evaluation of precursor prostate-specific antigen isoform ratios in the detection of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

27 September 2018

Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

27 September 2018

Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140702

27 September 2018

Pre-analytical in-vitro stability of [-2]proPSA in blood and serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/21419439

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

1 reference

https://pubmed.ncbi.nlm.nih.gov/21419439

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml

1 reference

https://pubmed.ncbi.nlm.nih.gov/21419439

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21419439

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additional use of [-2] precursor prostate-specific antigen and "benign" PSA at diagnosis in screen-detected prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21419439

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JURO.2010.12.032

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35119292&oldid=1746301894"